JP2002338554A - Bromotyrosine derivative and antimicrobial agent comprising the same as active ingredient - Google Patents

Bromotyrosine derivative and antimicrobial agent comprising the same as active ingredient

Info

Publication number
JP2002338554A
JP2002338554A JP2001144150A JP2001144150A JP2002338554A JP 2002338554 A JP2002338554 A JP 2002338554A JP 2001144150 A JP2001144150 A JP 2001144150A JP 2001144150 A JP2001144150 A JP 2001144150A JP 2002338554 A JP2002338554 A JP 2002338554A
Authority
JP
Japan
Prior art keywords
group
antibacterial agent
atom
agent according
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001144150A
Other languages
Japanese (ja)
Inventor
Daisuke Kamimura
大輔 上村
Akira Takada
晃 高田
Kiyotake Suenaga
聖武 末永
Kaoru Yamada
薫 山田
Reiko Watanabe
玲子 渡辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2001144150A priority Critical patent/JP2002338554A/en
Publication of JP2002338554A publication Critical patent/JP2002338554A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a new bromotyrosine derivative, its derivative and an antimicrobial agent containing the derivative or its salt as an active ingredient, especially an antimicrobial agent having excellent antibacterial activity against periphytic bacteria and high safety. SOLUTION: This bromotyrosine derivative is represented by formula (1) or its salt.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、新規なブロモチロ
シン誘導体又はその塩及びこれを有効成分とする抗菌剤
に関する。
TECHNICAL FIELD The present invention relates to a novel bromotyrosine derivative or a salt thereof and an antibacterial agent containing the same as an active ingredient.

【0002】[0002]

【従来の技術】カビや細菌はヒトに種々の疾病を引き起
こす他、農林水産業、工業等広い範囲の産業及び生活の
場で様々な汚染の原因となり、例えば植物病原菌による
樹木、果樹、野菜などの疾病を引き起こす。カビや細菌
の防御のために各種の抗菌剤が用いられているが、常に
より有効で安全かつ入手しやすいものが求められている
のみならず、耐性種との関連で新規な抗菌剤が求められ
ている。
2. Description of the Related Art Molds and bacteria cause various diseases in humans, and cause various pollutions in a wide range of industries and places of life such as agriculture, forestry and fisheries, industry, and the like. For example, trees, fruit trees, vegetables, etc. caused by phytopathogenic bacteria. Cause illness. Various antibacterial agents are used to protect against fungi and bacteria, but not only are they always needed to be more effective, safe and easily available, but new antibacterial agents are also required in relation to resistant species. Have been.

【0003】また、近年、各種水系の微生物による障害
が多発し、種々の弊害をもたらしている。例えば、石油
化学工場などで用いられている循環冷却方式の熱交換器
や配管などにバクテリアや糸状菌に由来するスライムが
発生し、これらスライムがパイプを閉塞して冷却効率を
低下させたり、また海洋においては、これらスライムが
バイオフィルム(スライムが物体を被覆するように付着
したもの)を形成してフジツボ等の大型生物の付着を促
進し、船舶、海上構築物、漁網等で被害が増大してい
る。従来、スライムやバイオフィルム等の付着防止策と
して、船底、船舶、海上構築物の没水部分や漁網等に有
機スズ化合物、銅化合物などを配合した防汚塗料が塗装
・塗布されてきた(例えば、Chemistry&In
dustry,5 March 1990,123−1
27頁参照)。しかしながら、銅やスズ化合物を配合し
た防汚塗料の長時間使用による海水汚染が問題となって
おり、銅やスズ化合物等の有機金属を含有しない安全性
の高い防汚塗料の開発が要望されている。
[0003] In recent years, various types of water-borne microorganisms have frequently caused obstacles, causing various adverse effects. For example, slime derived from bacteria and filamentous fungi occurs in heat exchangers and pipes of the circulating cooling system used in petrochemical plants, etc., and these slimes block pipes and reduce cooling efficiency, or In the ocean, these slimes form biofilms (the slimes are attached so as to cover objects) and promote the attachment of large organisms such as barnacles, increasing damage on ships, marine structures, fishing nets, etc. I have. Conventionally, as a measure to prevent adhesion of slime, biofilm, etc., antifouling paints containing an organotin compound, a copper compound, and the like have been applied to the bottom of a ship, a submerged portion of a marine structure, a fishing net, or the like (for example, Chemistry & In
dusty, 5 March 1990, 123-1
See page 27). However, seawater contamination due to long-term use of antifouling paints containing copper and tin compounds has become a problem, and there has been a demand for the development of highly safe antifouling paints that do not contain organic metals such as copper and tin compounds. I have.

【0004】ところで、カイメン類は約6000種が知
られている後生動物の一門であり、これまでに例えばイ
ソカイメン目のクロイソカイメン(Halichond
oria okadai)から得られたオカダ酸(J.
Am.Chem.Soc.,1981,103,246
9.)やハリコンドリン類(J.Am.Chem.So
c.,1985,107,4796.他)をはじめ種々
の生物活性を有する化合物が報告されており、本発明で
用いたカイメン(Pseudoceratina pu
rpurea)についても含有成分の検討が行われた報
告例(例えば、Tetrahedron Lett.,
1998,4147.; Tetrahedron,1
996,52,8181.; J.Org.Che
m.,1996,61,2936.他)はある。
[0004] By the way, sponges are a class of metazoan animals of which about 6000 species are known.
okadaic acid (J. oria okadai) (J.
Am. Chem. Soc. , 1981, 103, 246.
9. ) And halichondrins (J. Am. Chem. So
c. 1985, 107, 4796. Other compounds having various biological activities have been reported, including the sponge (Pseudoceratina pu) used in the present invention.
rpura) (for example, Tetrahedron Lett.)
1998, 4147. Tetrahedron, 1
996, 52, 8181. J .; Org. Che
m. , 1996, 61, 2936. Other) is.

【0005】また、例えば下記式(3)または(4)Further, for example, the following formula (3) or (4)

【0006】[0006]

【化3】 Embedded image

【0007】で表されるブロモチロシン誘導体が見出さ
れている(例えば、J.Chem.Soc.Chem.
Comm.,1970,752.; Tetrahed
ronLett.,1979,3921.; J.Na
tural Products,1989,52,75
3.; J.Natural Products,19
92,55,822.; J.Natural Pro
ducts,1994,57,705.; Tetra
hedron,1996,52,8181.他)。
A bromotyrosine derivative represented by the following formula (for example, J. Chem. Soc. Chem.
Comm. , 1970, 752. ; Tetrahed
ronLett. 1979, 3921. J .; Na
Tural Products, 1989, 52, 75
3. J .; Natural Products, 19
92, 55, 822. J .; Natural Pro
ducts, 1994, 57, 705. ; Tetra
hedron, 1996, 52, 8181. other).

【0008】しかしながら、本発明で用いたカイメン
(Pseudoceratina purpurea)
からは上記式(1)で表される化合物を得たとの報告は
皆無である。また、これまでに報告されたブロモチロシ
ン誘導体は上記式(1)で表される本発明の化合物のよ
うにアミン型窒素を有するもの及びブロモチロシンから
脱炭酸した構造を有するものの報告も皆無である。
[0008] However, the sponge (Pseudoceratina purpurea) used in the present invention.
Has no report that the compound represented by the above formula (1) has been obtained. In addition, there has been no report of a bromotyrosine derivative which has been reported so far, such as the compound of the present invention represented by the above formula (1), which has an amine-type nitrogen and has a structure decarboxylated from bromotyrosine. .

【0009】さらに、公知のブロモチロシン誘導体につ
いて抗菌性(例えば、J.Natural Produ
cts,1990,53,615.; Tetrahe
dron,1996,52,8181.他)、細胞毒性
(例えば、Tetrahedron Lett.,19
79,3921.; J.Natural Produ
cts,1992,55,822.他)、酵素阻害活性
(Tetrahedron Lett.,1985,4
517.; Experientia,1990,4
6,548.)、抗ウィルス活性(J.Natural
Products,1992,55,509.)等を
有するとの報告があるものの、上記式(1)で表される
化合物のごとく、少量で有意の抗菌活性を示したとの報
告例は見られない。
Further, known bromotyrosine derivatives have antibacterial properties (for example, J. Natural Produ).
cts, 1990, 53, 615. Tetrahe;
dron, 1996, 52, 8181. Et al.), Cytotoxicity (eg, Tetrahedron Lett., 19).
79, 3921. J .; Natural Produ
cts, 1992, 55, 822. Et al.), Enzyme inhibitory activity (Tetrahedron Lett., 1985, 4).
517. Experientia, 1990, 4
6,548. ), Antiviral activity (J. Natural
Products, 1992, 55, 509. ) Etc., but there is no report showing that a small amount showed significant antibacterial activity like the compound represented by the formula (1).

【0010】[0010]

【発明が解決しようとする課題】本発明は上記事情に鑑
みなされたものであり、新規なブロモチロシン誘導体及
びその塩を提供すると共に、これを有効成分とする抗菌
剤、特に付着性細菌に対して優れた抗菌活性を有する安
全性の高い抗菌剤を提供することを目的とする。
SUMMARY OF THE INVENTION The present invention has been made in view of the above circumstances, and provides a novel bromotyrosine derivative and a salt thereof, as well as an antibacterial agent containing the bromotyrosine derivative as an active ingredient, especially against adherent bacteria. It is intended to provide a highly safe antibacterial agent having excellent antibacterial activity.

【0011】[0011]

【課題を解決するための手段】本発明者らは上記課題を
解決するため鋭意検討を重ね本発明に想到したものであ
り、沖縄県座間味諸島近海で採集したカイメンから分離
した上記式(1)で表されるブロモチロシン誘導体が、
海洋付着性細菌の1種であるロドスピリルム・サレキシ
ゲンス(Rhodospirillum sarexi
gens)SCRC−113に対して増殖阻害活性を有
することを見出し、本発明を完成した。なお、この菌株
は工業技術院生命工学工業技術研究所にFERM P−
13599として寄託されている(特開平6−3274
95号公報参照)。
Means for Solving the Problems The present inventors have made intensive studies to solve the above-mentioned problems, and have arrived at the present invention. The above-mentioned formula (1) separated from sponges collected near the Zamami Islands in Okinawa Prefecture, Japan. The bromotyrosine derivative represented by
Rhodospirillum salexigen, one of the marine adherent bacteria, is
gens) have been found to have growth inhibitory activity against SCRC-113, and thus have completed the present invention. In addition, this strain was sent to FERM P-
No. 13599 (JP-A-6-3274).
No. 95).

【0012】すなわち、本発明は式(1)That is, the present invention relates to formula (1)

【0013】[0013]

【化4】 Embedded image

【0014】で表されるブロモチロシン誘導体又はその
塩に関する(第1の発明)。
A first aspect of the present invention relates to a bromotyrosine derivative represented by the formula (1) or a salt thereof.

【0015】また、第1の発明において、カイメン類の
Pseudoceratina purpureaから
抽出・分離精製されたブロモチロシン誘導体又はその塩
に関する(第2の発明)。
Further, in the first invention, the present invention relates to a bromotyrosine derivative or a salt thereof extracted and separated and purified from sponge Pseudoceratina purpurea (a second invention).

【0016】また、第1の発明か第2の発明のいずれか
のブロモチロシン誘導体又はその塩を有効成分とする抗
菌剤に関する(第3の発明)。第3の発明において、付
着性細菌に対する抗菌活性を有する第3の発明に記載の
抗菌剤に関する(第4の発明)。ここで付着性細菌と
は、水系、例えば配水管内にスライムを形成したり、海
洋での生物汚損においてフジツボなどの大型生物の付着
に先立ってバイオフィルムを形成する細菌のことをい
う。第4の発明において、付着性細菌はロドスピリルム
(Rhodospirillum)属である抗菌剤に関
する(第5の発明)。第5の発明において、ロドスピリ
ルム(Rhodospirillum)属の細菌がロド
スピリルム サレキシゲンス(Rhodospiril
lum sarexigens)SCRC−113(F
ERMP−13599)である抗菌剤に関する(第6の
発明)。
Also, the present invention relates to an antibacterial agent comprising a bromotyrosine derivative or a salt thereof according to any one of the first and second aspects as an active ingredient (third aspect). In the third invention, the present invention relates to the antibacterial agent according to the third invention, which has an antibacterial activity against adherent bacteria (fourth invention). Here, the adherent bacterium refers to a bacterium that forms a slime in a water system, for example, a water distribution pipe, or forms a biofilm prior to the attachment of large organisms such as barnacles in biofouling in the ocean. In the fourth invention, the adherent bacterium relates to an antibacterial agent belonging to the genus Rhodospirillum (fifth invention). In the fifth invention, a bacterium belonging to the genus Rhodospirillum is Rhodospirillum.
lum salexigens) SCRC-113 (F
ERMP-13599) (sixth invention).

【0017】また、第3の発明から第6の発明のいずれ
かの抗菌剤を塗布又は含浸させた網に関する(第7の発
明)。網は海洋、河川などの水系で用いられる網で、漁
網やサメ避け用ネットなどを例示できる。第3の発明か
ら第6の発明のいずれかの抗菌剤を塗布又は含浸させた
ロープに関する(第8の発明)。ロープは海洋、河川な
どの水系で用いられるロープを意味する。第3の発明か
ら第6の発明のいずれかの抗菌剤を塗布又は含浸させた
ブイに関する(第9の発明)。第3の発明から第6の発
明のいずれかの抗菌剤を含有する塗料に関する(第10
の発明)。第3の発明から第6の発明のいずれか1項に
記載の抗菌剤を含有する顔料に関する(第11の発
明)。第3の発明から第6の発明のいずれかの抗菌剤を
含有する防錆剤に関する(第12の発明)。
Further, the present invention relates to a net coated or impregnated with the antibacterial agent according to any one of the third to sixth aspects (seventh aspect). The net is a net used in a water system such as an ocean or a river, and examples thereof include a fishing net and a shark avoiding net. The present invention relates to a rope coated or impregnated with the antibacterial agent according to any one of the third to sixth inventions (eighth invention). A rope means a rope used in a water system such as an ocean or a river. The present invention relates to a buoy coated or impregnated with the antibacterial agent according to any one of the third to sixth inventions (a ninth invention). The present invention relates to a paint containing the antibacterial agent according to any one of the third invention to the sixth invention (No. 10).
Invention). A pigment containing the antibacterial agent according to any one of the third to sixth inventions (an eleventh invention). The present invention relates to a rust inhibitor containing the antibacterial agent of any one of the third to sixth inventions (twelfth invention).

【0018】また、式(2)Equation (2)

【0019】[0019]

【化5】 Embedded image

【0020】(式中、R、R、R1’、R2’は独
立に水素原子又はフッ素原子、塩素原子、臭素原子ある
いはヨウ素原子を表す。R、R、R3’、R4’
独立に水素原子、保護基を有していてもよい水酸基ある
いはアミノ基、低級アルキル基、アルケニル基、アルコ
キシ基またはアルキルアミノ基を表す。R、R5’
独立に水素原子またはアミノ基の保護基を表す。X、X
は独立に酸素原子または簡単な置換基を有していても
よい窒素原子、イオウ原子あるいはリン原子を表す。)
で表される化合物又はその塩に関する(第13の発
明)。
(Wherein R 1 , R 2 , R 1 ′ and R 2 ′ independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom or an iodine atom; R 3 , R 4 , R 3 ′ , R 4 ′ independently represents a hydrogen atom, a hydroxyl group which may have a protecting group, an amino group, a lower alkyl group, an alkenyl group, an alkoxy group or an alkylamino group, and R 5 and R 5 ′ each independently represent a hydrogen atom. Or a protecting group for an amino group.
' Independently represents an oxygen atom or a nitrogen atom, a sulfur atom or a phosphorus atom which may have a simple substituent. )
Or a salt thereof (a thirteenth invention).

【0021】[0021]

【発明の実施の形態】本発明の上記式(1)で表される
ブロモチロシン誘導体は沖縄県座間味諸島近海で採集し
た海洋生物、例えばカイメン(Pseudocerat
ina purpurea)を有機溶媒で抽出後、分離
精製することにより得ることができる。
BEST MODE FOR CARRYING OUT THE INVENTION The bromotyrosine derivative represented by the above formula (1) of the present invention is a marine organism collected near the Zamami Islands in Okinawa Prefecture, for example, sponge (Pseudocerat).
Ina purpura) can be obtained by extracting with an organic solvent, followed by separation and purification.

【0022】抽出に用いる溶媒としては、メタノール、
エタノール、アセトン、酢酸エチル、クロロホルム、ベ
ンゼン、ヘキサン等が挙げられる。また分離精製は公知
の方法を用いることができ、クロマトグラフィはカラム
クロマトグラフィ、薄層クロマトグラフィ及び高速液体
クロマトグラフィ等を単独あるいは組み合わせて用いる
ことができ、またカラムクロマトグラフィとしてはシリ
カゲルの他、セファデックスLH20、逆相系のRP−
18等を用いることができ、薄層クロマトグラフィ及び
高速液体クロマトグラフィとしては、シリカゲルの他、
RP−18等が用いられる。
As the solvent used for the extraction, methanol,
Examples include ethanol, acetone, ethyl acetate, chloroform, benzene, and hexane. Known methods can be used for separation and purification. Chromatography can be used alone or in combination with column chromatography, thin-layer chromatography, high performance liquid chromatography, and the like. In addition to silica gel, Sephadex LH20, reverse Phase-related RP-
18 or the like can be used. As thin-layer chromatography and high-performance liquid chromatography, in addition to silica gel,
RP-18 or the like is used.

【0023】本発明の上記式(1)で表されるブロモチ
ロシン誘導体は抗菌性に優れると共に、種々の薬理活性
が期待される。
The bromotyrosine derivative of the present invention represented by the above formula (1) has excellent antibacterial properties and is expected to have various pharmacological activities.

【0024】本発明の上記式(1)で表されるブロモチ
ロシン誘導体を抗菌剤として用いる場合、そのままの形
態で用いてもよいが製剤化して用いてもよい。製剤化す
る場合は、慣用の希釈剤、担体、増量剤、添加剤などを
使用することができる。本発明の抗菌剤は糸状菌や海洋
細菌によるスライム形成の防御に用いることができる。
具体的には衣類、食器、医療器具などの消毒殺菌に使用
できる他、産業用製造工程または家畜舎などの消毒防臭
剤、植物抗菌剤、プール、冷却水等の水処理用の殺菌
剤、スライムコントロール剤、水系汚染防止剤などとし
て有用である。
When the bromotyrosine derivative of the present invention represented by the above formula (1) is used as an antibacterial agent, it may be used as it is, or may be used as a formulation. In the case of formulation, conventional diluents, carriers, extenders, additives and the like can be used. The antibacterial agent of the present invention can be used for protection against slime formation by filamentous fungi and marine bacteria.
Specifically, it can be used for disinfecting and disinfecting clothing, tableware, medical equipment, etc., as well as disinfecting and deodorizing agents for industrial manufacturing processes or livestock sheds, plant antibacterial agents, disinfectants for water treatment such as pools and cooling water, slime It is useful as a control agent, an aqueous pollution control agent, and the like.

【0025】本発明の抗菌剤が抗菌活性を有する付着細
菌は、物体に付着してスライムやバイオフィルムを形成
する能力を有するものであればよく、既述のロドスピリ
ルム属の細菌の他、シクロバクテリウム属、ハイフォミ
クロビウム属、ハイフォモナス属、ペヂオミクロビウム
属、プロセセコミクロビウム属、アルテコモナス属、デ
レヤ属、シュードモナス属、マリノモナス属などの属す
る細菌を例示できる。
The adherent bacterium which the antibacterial agent of the present invention has an antibacterial activity may be any as long as it has an ability to adhere to an object to form a slime or a biofilm. Bacteria belonging to the genus Aum, Hyphomicrobium, Hyphomonas, Pedimicrobium, Prosececomicrobium, Artecomonas, Delaea, Pseudomonas, Marinomonas, etc. can be exemplified.

【0026】また、本発明の抗菌剤を漁網などの網や海
洋や河川などで用いるロープなどに塗布又は含浸させて
用いることができる。また、ブイなどの海洋や河川など
で用いられる部材に塗布又は含浸させて用いることもで
き、糸状菌や付着細菌が網、ロープあるいはブイなどに
スライムを形成したりバイオフィルムを形成することを
防止できる。また、前記抗菌剤を塗料、顔料あるいは防
錆剤などに含有させて用いることもできる。
The antibacterial agent of the present invention can be used by being applied or impregnated on nets such as fishing nets, ropes used in oceans and rivers, and the like. In addition, it can be used by applying or impregnating it to members used in oceans and rivers such as buoys, preventing filamentous fungi and attached bacteria from forming slime and biofilms on nets, ropes or buoys etc. it can. Further, the antibacterial agent can be used by being contained in a paint, a pigment, a rust inhibitor or the like.

【0027】また、本発明の抗菌剤は式(1)で表され
るブロモチロシン誘導体の塩としても用いることがで
き、このような塩には無機又は有機酸付加塩があり、例
えば塩酸塩、リン酸塩、硫酸塩、クエン酸塩、酒石酸
塩、マレイン酸塩、フマル酸塩、シュウ酸塩、安息香酸
塩等が挙げられるが、これらに限定されるものではな
く、また従来より公知の方法で塩を形成できる。
The antibacterial agent of the present invention can also be used as a salt of a bromotyrosine derivative represented by the formula (1). Such salts include inorganic or organic acid addition salts, for example, hydrochloride, Phosphate, sulfate, citrate, tartrate, maleate, fumarate, oxalate, benzoate and the like, but are not limited thereto, and conventionally known methods Can form a salt.

【0028】また、式(2)の化合物又はその塩も式
(1)のブロモチロシン誘導体と同様に抗菌活性あるい
は種々の薬理活性が期待される。式(2)の化合物又は
その塩は、式(1)のボロモチロシン誘導体と同様に製
剤化して用いることもでき、抗菌剤として特に付着性細
菌に好適に用いることができる。更に、式(2)の化合
物又はその塩は、ロープ、ブイに塗布・含浸させたり、
塗料、顔料又は防錆剤に含有させて用いることもでき
る。式(2)において、水酸基あるいはアミノ基の保護
基としては、アセチル基、プロピオニル基、ピバロイル
基、ベンゾイル基等のアシル基;メトキシカルボニル
基、t−ブトキシカルボニル基等のアルコキシカルボニ
ル基;ベンジルオキシカルボニル基等のアラルキルオキ
シカルボニル基;ベンジル基、ナフチルメチル基等のア
リールメチル基;トリメチルシリル基、トリエチルシリ
ル基、ベンジルジメチルシリル基、t−ブチルジフェニ
ルシリル基等のシリル基;アセトニド基;ヒドロキシメ
チル基、メトキシメチル基等の低級アルコキシメチル基
などを例示することができる。また、低級アルキル基と
は、炭素数1から6の直鎖状、分枝状もしくは環状のア
ルキル基を意味し、その具体例としてメチル基、エチル
基、プロピル基、イソプロピル基、ブチル基、イソブチ
ル基、sec−ブチル基、ペンチル基、ヘキシル基、シ
クロプロピル基、シクロペンチル基、シクロヘキシル基
等を挙げることができる。アルケニル基としては、特に
炭素数1から6の直鎖状もしくは分枝状のものが好まし
く、エテニル基、プロペニル基、ブテニル基、イソブテ
ニル基、sec−ブテニル基、ペンテニル基、ヘキセニ
ル基等を挙げることができる。アルコキシ基とは、炭素
数1から6の直鎖状もしくは分枝状のアルコキシ基を意
味し、その具体例としてメトキシ基、エトキシ基、プロ
ポキシ基、イソプロポキシ基、ブトキシ基、イソブトキ
シ基、ペンチルオキシ基、ヘキシルオキシ基を挙げるこ
とができ、シクロアルコキシ基としては、シクロプロピ
ルオキシ基、シクロペンチルオキシ基等を挙げることが
できる。アルキルアミノ基とは、水素原子の1つ又は両
方が低級アルキル基に置換されたアミノ基を意味し、そ
の具体例としてN−メチルアミノ基、N−エチルアミノ
基、N−プロピルアミノ基、N−イソプロピルアミノ
基、N,N−ジメチルアミノ基、N,N−ジエチルアミ
ノ基、N−エチル−N−メチルアミノ基、N,N−ジプ
ロピルアミノ基等を挙げることができる。簡単な置換基
とは、水素原子、酸素原子または低級アルキル基をい
う。なお、式(2)の化合物の塩は、式(1)のブロモ
チロシン誘導体の塩と同様に無機又は有機酸付加塩とし
て用いることができる。
The compound of the formula (2) or a salt thereof is expected to have antibacterial activity or various pharmacological activities like the bromotyrosine derivative of the formula (1). The compound of the formula (2) or a salt thereof can be formulated and used in the same manner as the boromotyrosine derivative of the formula (1), and can be suitably used as an antibacterial agent, particularly for adherent bacteria. Further, the compound of the formula (2) or a salt thereof may be applied and impregnated on a rope or buoy,
It can be used by being contained in a paint, a pigment or a rust preventive. In the formula (2), as a protecting group for a hydroxyl group or an amino group, an acyl group such as an acetyl group, a propionyl group, a pivaloyl group and a benzoyl group; an alkoxycarbonyl group such as a methoxycarbonyl group and a t-butoxycarbonyl group; An aralkyloxycarbonyl group such as a group; an arylmethyl group such as a benzyl group and a naphthylmethyl group; a silyl group such as a trimethylsilyl group, a triethylsilyl group, a benzyldimethylsilyl group and a t-butyldiphenylsilyl group; an acetonide group; Examples thereof include a lower alkoxymethyl group such as a methoxymethyl group. The lower alkyl group means a linear, branched or cyclic alkyl group having 1 to 6 carbon atoms, and specific examples thereof include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group and an isobutyl group. Group, sec-butyl group, pentyl group, hexyl group, cyclopropyl group, cyclopentyl group, cyclohexyl group and the like. The alkenyl group is particularly preferably a straight-chain or branched one having 1 to 6 carbon atoms, and includes ethenyl, propenyl, butenyl, isobutenyl, sec-butenyl, pentenyl, hexenyl and the like. Can be. The alkoxy group means a linear or branched alkoxy group having 1 to 6 carbon atoms, and specific examples thereof include methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, and pentyloxy. And a hexyloxy group. Examples of the cycloalkoxy group include a cyclopropyloxy group and a cyclopentyloxy group. The alkylamino group means an amino group in which one or both of the hydrogen atoms is substituted by a lower alkyl group, and specific examples thereof include an N-methylamino group, an N-ethylamino group, an N-propylamino group, -Isopropylamino group, N, N-dimethylamino group, N, N-diethylamino group, N-ethyl-N-methylamino group, N, N-dipropylamino group and the like. Simple substituents refer to a hydrogen atom, an oxygen atom or a lower alkyl group. The salt of the compound of the formula (2) can be used as an inorganic or organic acid addition salt in the same manner as the salt of the bromotyrosine derivative of the formula (1).

【0029】また、本発明の上記式(1)で表されるブ
ロモチロシン誘導体は、公知の方法を用いて化学修飾を
行いやすいので、抗菌剤等としてより優れた性質を有す
る誘導体に変換して用いることもできる。
The bromotyrosine derivative of the present invention represented by the above formula (1) can be easily modified by a known method, so that it can be converted into a derivative having more excellent properties as an antibacterial agent and the like. It can also be used.

【0030】[0030]

【実施例】次いで、本発明を実施例を挙げて説明する
が、本発明は既述の発明の実施の形態及び以下の実施例
に限定されるものではない。
EXAMPLES Next, the present invention will be described with reference to examples, but the present invention is not limited to the above-described embodiments and the following examples.

【0031】(ブロモチロシン誘導体(1)の分離精
製)沖縄県座間味諸島近海で採集したカイメン(Pse
udoceratinapurpurea)240gを
アセトン1Lを加えてウォーリングブレンダーを用いて
粉砕した。室温で3日間静置後、濾過し、濾液を加熱減
圧下有機溶媒を留去した。水性残渣を酢酸エチル(0.
5L)で3回抽出し、合わせて溶媒を留去濃縮して粗抽
出物1.98gを得た。
(Separation and Purification of Bromotyrosine Derivative (1)) Sponge (Pse) collected near the Zamami Islands in Okinawa Prefecture
240 g of udoceratinapurpura) was added to 1 L of acetone and pulverized using a Waring blender. After allowing to stand at room temperature for 3 days, the mixture was filtered, and the filtrate was heated and the organic solvent was distilled off under reduced pressure. The aqueous residue was washed with ethyl acetate (0.
5L), and the solvent was distilled off and concentrated to obtain 1.98 g of a crude extract.

【0032】上記粗抽出物をヘキサン100mLと90
%メタノール100mLに分配し、90%メタノール層
をヘキサン100mLで更に2回洗浄した後、加熱減圧
下有機溶媒を留去して90%メタノール可溶画分を1.
36g得た。
The above crude extract was mixed with 100 mL of hexane and 90 mL
Then, the 90% methanol layer was further washed twice with 100 mL of hexane, and the organic solvent was distilled off under reduced pressure with heating to obtain a 90% methanol-soluble fraction.
36 g were obtained.

【0033】ガラスカラムにクロロホルム/メタノール
=50/1で懸濁させたシリカゲル50gを充填し、少
量のクロロホルム/メタノール=50/1に溶解した上
記90%メタノール可溶画分をこれに吸着させた。この
カラムに順次クロロホルム/メタノール=50/1、ク
ロロホルム/メタノール=20/1、クロロホルム/メ
タノール=9/1、メタノールを各4倍カラム容量流し
た。クロロホルム/メタノール=50/1の後半と20
/1溶出画分の前半を集めて濃縮し黄色油状物263m
gを得た。
A glass column was filled with 50 g of silica gel suspended in chloroform / methanol = 50/1, and the above 90% methanol-soluble fraction dissolved in a small amount of chloroform / methanol = 50/1 was adsorbed thereto. . Chloroform / methanol = 50/1, chloroform / methanol = 20/1, chloroform / methanol = 9/1, and methanol were sequentially flown through this column by four column volumes. Chloroform / methanol = latter half of 50/1 and 20
The first half of the / 1 eluted fraction was collected and concentrated to a yellow oily substance (263 m).
g was obtained.

【0034】ガラスカラムにベンゼン/アセトン=4/
1で懸濁させたシリカゲル20gを充填し、少量のベン
ゼン/アセトン=4/1に溶解した上記黄色油状物をこ
れに吸着させた。このカラムに順次ベンゼン/アセトン
=4/1、ベンゼン/アセトン=2/1、ベンゼン/ア
セトン=1/1、アセトン、メタノールを各3倍カラム
容量流した。ベンゼン/アセトン=4/1溶出画分の最
初の約1/2をまとめて濃縮し黄色油状物84.2mg
を得た。
In a glass column, benzene / acetone = 4 /
20 g of silica gel suspended in 1 was filled, and the yellow oil dissolved in a small amount of benzene / acetone = 4/1 was adsorbed thereto. To this column, benzene / acetone = 4/1, benzene / acetone = 2/1, benzene / acetone = 1/1, acetone, and methanol were respectively flown in three column volumes. The first about 分 の of the benzene / acetone = 4/1 elution fraction was combined and concentrated to 84.2 mg of a yellow oil.
I got

【0035】ガラスカラムにクロロホルム/酢酸エチル
=4/1で懸濁させたシリカゲル7gを充填し、少量の
クロロホルム/酢酸エチル=4/1に溶解した上記黄色
油状物をこれに吸着させた。このカラムに順次クロロホ
ルム/酢酸エチル=4/1、クロロホルム/酢酸エチル
=2/1、クロロホルム/酢酸エチル=1/1、クロロ
ホルム/酢酸エチル=1/2、酢酸エチル、メタノール
を各4倍カラム容量流した。クロロホルム/酢酸エチル
=2/1溶出画分を集めて濃縮し黄色油状物19.0m
gを得た。
A glass column was filled with 7 g of silica gel suspended in chloroform / ethyl acetate = 4/1, and the yellow oil dissolved in a small amount of chloroform / ethyl acetate = 4/1 was adsorbed thereto. In this column, chloroform / ethyl acetate = 4/1, chloroform / ethyl acetate = 2/1, chloroform / ethyl acetate = 1/1, chloroform / ethyl acetate = 1/2, ethyl acetate, and methanol were each quadrupled in column capacity. Shed. The fraction eluted with chloroform / ethyl acetate = 2/1 was collected and concentrated to give a yellow oily substance of 19.0 m
g was obtained.

【0036】上記黄色油状物を少量の(クロロホルム/
酢酸エチル=10/1)溶液とし、高速液体クロマトグ
ラフィー(カラム:Develosil 30−3、2
0mm×250mm;溶媒:クロロホルム/酢酸エチル
=10/1;流速:5.0mL/min.;検出:UV
254nm)に注入して保持時間75分から130分ま
でを分取、濃縮して、無色油状物を13.2mg得た。
A small amount of the above yellow oil (chloroform /
Ethyl acetate = 10/1) solution, and high performance liquid chromatography (column: Develosil 30-3, 2)
0 mm × 250 mm; solvent: chloroform / ethyl acetate = 10/1; flow rate: 5.0 mL / min. ; Detection: UV
254 nm), and the mixture was collected for a retention time of 75 minutes to 130 minutes and concentrated to give 13.2 mg of a colorless oil.

【0037】上記無色油状物を少量の40%メタノール
溶液とし、高速液体クロマトグラフィー(カラム:YM
C−Pack ODS−AQ、10mm×250mm;
溶媒:40%メタノール−水;流速:2.0mL/mi
n.;検出:UV254nm)に注入して保持時間13
分から26分までを分取、濃縮して、無色油状物を1
1.9mg得た。
The above colorless oil was converted into a small amount of a 40% methanol solution and subjected to high performance liquid chromatography (column: YM
C-Pack ODS-AQ, 10 mm x 250 mm;
Solvent: 40% methanol-water; flow rate: 2.0 mL / mi
n. ; Detection: UV 254 nm) and retention time 13
From 26 minutes to 26 minutes and concentrated to give a colorless oil
1.9 mg were obtained.

【0038】上記無色油状物を少量の10%メタノール
溶液とし、高速液体クロマトグラフィー(カラム:YM
C−Pack ODS−AQ、4.6mm×150m
m;溶媒:10%メタノール−水;流速:1.0mL/
min.;検出:UV254nm)に注入して保持時間
25分から27分までを分取、濃縮して、ブロモチロシ
ン誘導体(1)0.82mgを無色油状物として得た。
The above colorless oil was converted into a small amount of a 10% methanol solution and subjected to high performance liquid chromatography (column: YM
C-Pack ODS-AQ, 4.6 mm x 150 m
m; solvent: 10% methanol-water; flow rate: 1.0 mL /
min. Detection: UV 254 nm), fractionated for a retention time of 25 to 27 minutes, and concentrated to give 0.82 mg of the bromotyrosine derivative (1) as a colorless oil.

【0039】分子式 :C1818Br
H−NMR(800MHz、CDCl):δ2.4
5(1H、d、J=5.1Hz、1−OH)、2.52
(1H、s、8−NH)、2.81(1H、d、J=1
6Hz、7a−H)、2.85(1H、d、J=16H
z、7b−H)、3.77(3H、s、3−OMe)、
4.44(1H、d、J=5.1Hz、1−H)、6.
42(1H、s、5−H) H−NMR(800MHz、CDOD):δ2.8
1(1H、d、J=17Hz、7a−H)、2.85
(1H、d、J=17Hz、7b−H)、3.73(3
H、s、3−OMe)、4.11(1H、d、J=1.
1Hz、1−H)、6.34(1H、d、J=1.1H
z、5−H)13 C−NMR(200MHz、CDCl):δ2
5.5(t、7−C)、60.3(q、3−OMe)、
74.3(s、6−C)、77.4(d、1−C)、1
12.3(s、2−C)、116.6(s、8−C)、
121.2(s、4−C)、131.6(d、5−
C)、148.1(s、3−C) IR(CHCl):3580、3350(br)、1
580cmー1 [α]29 +248°(c 0.012、CHCl
) ESIMS(m/z): 696.7766(Δ2.9
mmu)[M+Na]
Molecular formula: C 18 H 18 Br 4 N 2
O 6 1 H-NMR (800MHz , CDCl 3): δ2.4
5 (1H, d, J = 5.1 Hz, 1-OH), 2.52
(1H, s, 8-NH), 2.81 (1H, d, J = 1
6Hz, 7a-H), 2.85 (1H, d, J = 16H)
z, 7b-H), 3.77 (3H, s, 3-OMe),
5.44 (1H, d, J = 5.1 Hz, 1-H);
42 (1H, s, 5- H) 1 H-NMR (800MHz, CD 3 OD): δ2.8
1 (1H, d, J = 17 Hz, 7a-H), 2.85
(1H, d, J = 17 Hz, 7b-H), 3.73 (3
H, s, 3-OMe), 4.11 (1H, d, J = 1.
1 Hz, 1-H), 6.34 (1 H, d, J = 1.1 H)
z, 5-H) 13 C-NMR (200 MHz, CDCl 3 ): δ2
5.5 (t, 7-C), 60.3 (q, 3-OMe),
74.3 (s, 6-C), 77.4 (d, 1-C), 1
12.3 (s, 2-C), 116.6 (s, 8-C),
121.2 (s, 4-C), 131.6 (d, 5-
C), 148.1 (s, 3 -C) IR (CHCl 3): 3580,3350 (br), 1
580 cm -1 [α] 29 D + 248 ° (c 0.012, CHCl
3 ) ESIMS (m / z): 696.7766 (Δ2.9)
mmu) [M + Na] + .

【0040】(抗菌活性試験)抗菌活性試験はディスク
拡散法により以下のように行った。液体培地(ペプトン
0.5%、イーストエキス0.1%、1/2濃度人工海
水)中で3日間培養したロドスピリルム サレキシゲン
ス(Rhodospirillum sarexige
ns)SCRC−113培養液の100μLを直径85
mmのシャーレに作成した抗菌試験用寒天平板(ペプト
ン0.5%、イーストエキス0.1%、寒天1.5%、
1/2濃度人工海水)に塗布した。実施例1で得られた
ブロモチロシン誘導体(1)の所定濃度を含むメタノー
ル溶液の15μLをオートクレーブ滅菌した円形ろ紙
(直径6mm)の載せ、前記平板上に静かに置いた。2
5℃で3日間培養後、阻止円の直径を計った。その結
果、ディスク当り1.6μgのブロモチロシン誘導体
(1)を載せた(1.6μg/disk)場合、阻止円
の直径は21mmでブロモチロシン誘導体は付着性細菌
に対する抗菌活性に優れることが確認された。尚、例え
ば既知のブロモチロシン誘導体の中でも抗菌性が比較的
強いとされる(2c)や(3c)の場合、10μg/d
iskで10mm程度の阻止円が観測されたとの報告が
ある(J.Natural Products,199
0,53,615.; Tetrahedron,19
96,52,8181.)。
(Antibacterial activity test) The antibacterial activity test was performed by the disk diffusion method as follows. Rhodospirillum salexigens cultured in a liquid medium (0.5% peptone, 0.1% yeast extract, 1/2 concentration artificial seawater) for 3 days
ns) 100 μL of the SCRC-113 culture solution was applied to a diameter of 85
agar plate for antibacterial test (peptone 0.5%, yeast extract 0.1%, agar 1.5%,
(1/2 concentration artificial seawater). 15 μL of a methanol solution containing a predetermined concentration of the bromotyrosine derivative (1) obtained in Example 1 was placed on autoclave-sterilized circular filter paper (6 mm in diameter), and gently placed on the flat plate. 2
After culturing at 5 ° C. for 3 days, the diameter of the inhibition circle was measured. As a result, when 1.6 μg of the bromotyrosine derivative (1) was loaded per disk (1.6 μg / disk), the diameter of the blocking circle was 21 mm, and it was confirmed that the bromotyrosine derivative had excellent antibacterial activity against adherent bacteria. Was. For example, among the known bromotyrosine derivatives, (2c) and (3c), which are considered to have relatively strong antibacterial properties, 10 μg / d
It has been reported that an obstruction circle of about 10 mm was observed on an isk (J. Natural Products, 199).
0,53,615. Tetrahedron, 19;
96, 52, 8181. ).

【0041】[0041]

【発明の効果】本発明は上記で詳述したように構成され
るため以下の効果を奏する。本発明のブロモチロシン誘
導体及びその塩は、抗菌活性を有し抗菌剤として有用で
あり、特に付着性細菌に対して優れた抗菌活性を有し、
付着性細菌によるスライムやバイオフィルムの形成を阻
害するので、これらに起因する船舶、海上構築物、漁網
等の被害を防止できる。また、化学修飾が容易で誘導体
を合成しやすいので更に優れた活性を有する抗菌剤の開
発が期待できる。
The present invention has the following effects because it is configured as described above in detail. The bromotyrosine derivative and the salt thereof of the present invention have an antibacterial activity and are useful as an antibacterial agent, and particularly have an excellent antibacterial activity against adherent bacteria,
Since the formation of slime and biofilm by the adherent bacteria is inhibited, damage to ships, marine structures, fishing nets, and the like due to these can be prevented. In addition, development of an antibacterial agent having more excellent activity can be expected because of easy chemical modification and easy synthesis of a derivative.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C09D 201/00 C09D 201/00 // A61K 31/423 A61K 31/423 (72)発明者 渡辺 玲子 愛知県西春日井郡西枇杷島町城並2−10− 3 Fターム(参考) 4C056 AA01 AB01 AC01 AD09 AE02 AF08 4C086 AA01 AA02 AA03 BC68 GA09 MA01 MA04 NA14 ZB35 4C087 AA01 AA02 BB02 MA01 NA14 ZB35 4H011 AA02 AA03 AD01 BA01 BB10 DC10 DC11 DD01 DD07 4J038 EA011 JB38 KA02 KA05──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) C09D 201/00 C09D 201/00 // A61K 31/423 A61K 31/423 (72) Inventor Reiko Watanabe Nishi, Aichi 2-10-3 Nami-Biwajima-cho, Kasugai-gun Castle F-term (reference) 4C056 AA01 AB01 AC01 AD09 AE02 AF08 4C086 AA01 AA02 AA03 BC68 GA09 MA01 MA04 NA14 ZB35 4C087 AA01 AA02 BB02 MA01 NA14 ZB35 4H011 AA01 DC10 DD07 4J038 EA011 JB38 KA02 KA05

Claims (13)

【特許請求の範囲】[Claims] 【請求項1】次の式(1)、 【化1】 で表されるブロモチロシン誘導体又はその塩。(1) The following formula (1): Or a salt thereof. 【請求項2】カイメン類(Pseudoceratin
a purpurea)から抽出・分離精製された請求
項1に記載のブロモチロシン誘導体又はその塩。
2. A sponge (Pseudoceratin)
A bromotyrosine derivative or a salt thereof according to claim 1, which has been extracted, separated and purified from a purpura).
【請求項3】請求項1か請求項2のいずれか1項に記載
のブロモチロシン誘導体又はその塩を有効成分とする抗
菌剤。
3. An antimicrobial agent comprising the bromotyrosine derivative or a salt thereof according to claim 1 as an active ingredient.
【請求項4】付着性細菌に対する抗菌活性を有する請求
項3に記載の抗菌剤。
4. The antibacterial agent according to claim 3, which has an antibacterial activity against adherent bacteria.
【請求項5】付着性細菌はロドスピリルム(Rhodo
spirillum)属である請求項4に記載の抗菌
剤。
5. The adherent bacterium is Rhodospirillum (Rhodo).
The antibacterial agent according to claim 4, which belongs to the genus spirlum).
【請求項6】ロドスピリルム(Rhodospiril
lum)属の細菌がロドスピリルム サレキシゲンス
(Rhodospirillum sarexigen
s)SCRC−113(FERMP−13599)であ
る請求項5に記載の抗菌剤。
6. Rhodospiril (Rhodospiril)
lum) bacteria is Rhodospirillum salexigens (Rhodospirillum salexigen)
s) The antibacterial agent according to claim 5, which is SCRC-113 (FERMP-13599).
【請求項7】請求項3から請求項6のいずれか1項に記
載の抗菌剤を塗布又は含浸させた網。
7. A net coated or impregnated with the antibacterial agent according to any one of claims 3 to 6.
【請求項8】請求項3から請求項6のいずれか1項に記
載の抗菌剤を塗布又は含浸させたロープ。
8. A rope coated or impregnated with the antibacterial agent according to any one of claims 3 to 6.
【請求項9】請求項3から請求項6のいずれか1項に記
載の抗菌剤を塗布又は含浸させたブイ。
9. A buoy coated or impregnated with the antibacterial agent according to any one of claims 3 to 6.
【請求項10】請求項3から請求項6のいずれか1項に
記載の抗菌剤を含有する塗料。
10. A paint containing the antibacterial agent according to any one of claims 3 to 6.
【請求項11】請求項3から請求項6のいずれか1項に
記載の抗菌剤を含有する顔料。
11. A pigment containing the antibacterial agent according to any one of claims 3 to 6.
【請求項12】請求項3から請求項6のいずれか1項に
記載の抗菌剤を含有する防錆剤。
12. A rust preventive containing the antibacterial agent according to any one of claims 3 to 6.
【請求項13】次の一般式(2)、 【化2】 (式中、R、R、R1’、R2’は独立に水素原子
又はフッ素原子、塩素原子、臭素原子あるいはヨウ素原
子を表す。R、R、R3’、R4’は独立に水素原
子、保護基を有していてもよい水酸基あるいはアミノ
基、低級アルキル基、アルケニル基、アルコキシ基また
はアルキルアミノ基を表す。R、R5’は独立に水素
原子またはアミノ基の保護基を表す。X、Xは独立に
酸素原子または簡単な置換基を有していてもよい窒素原
子、イオウ原子あるいはリン原子を表す。)で表される
化合物又はその塩。
13. The following general formula (2): (Wherein, R 1 , R 2 , R 1 ′ and R 2 ′ independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom or an iodine atom. R 3 , R 4 , R 3 ′ , R 4 ′) Independently represents a hydrogen atom, a hydroxyl group or an amino group which may have a protecting group, a lower alkyl group, an alkenyl group, an alkoxy group or an alkylamino group, and R 5 and R 5 ′ independently represent a hydrogen atom or an amino group. X and X independently represent an oxygen atom or a nitrogen atom, a sulfur atom or a phosphorus atom which may have a simple substituent.) Or a salt thereof.
JP2001144150A 2001-05-15 2001-05-15 Bromotyrosine derivative and antimicrobial agent comprising the same as active ingredient Pending JP2002338554A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001144150A JP2002338554A (en) 2001-05-15 2001-05-15 Bromotyrosine derivative and antimicrobial agent comprising the same as active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001144150A JP2002338554A (en) 2001-05-15 2001-05-15 Bromotyrosine derivative and antimicrobial agent comprising the same as active ingredient

Publications (1)

Publication Number Publication Date
JP2002338554A true JP2002338554A (en) 2002-11-27

Family

ID=18990145

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001144150A Pending JP2002338554A (en) 2001-05-15 2001-05-15 Bromotyrosine derivative and antimicrobial agent comprising the same as active ingredient

Country Status (1)

Country Link
JP (1) JP2002338554A (en)

Similar Documents

Publication Publication Date Title
Xu et al. Potent antifouling compounds produced by marine Streptomyces
JP4533383B2 (en) Capsaicin derivatives and their production and use
US20080095737A1 (en) Non-toxic coating composition, methods of use thereof and articles protected from attachment of biofouling organisms
NZ289025A (en) Antifouling composition comprising substituted 3-butyl-furan-2-one and a carrier
CN102093322A (en) Application of osthole in preparation of marine antifouling paint
Feng et al. Synthesis, antibacterial activity, and application in the antifouling marine coatings of novel acylamino compounds containing gramine groups
CN102105542B (en) Antifouling furan-2-one derivatives
AU2001275527A1 (en) Non-toxic coating composition, methods of use thereof and articles protected from attachment of biofouling organisms
JP2008504377A (en) Environmentally friendly antifouling agent
JP2008502769A (en) Environmentally friendly antifouling agent
Li et al. Investigation on the efficiency of a silicone antifouling coating in controlling the adhesion and germination of Ulva prolifera micro-propagules on rafts
JP4982709B2 (en) Antiadhesive agent for adhering diatoms
JP2002338554A (en) Bromotyrosine derivative and antimicrobial agent comprising the same as active ingredient
US20060217456A1 (en) Non-toxic coating composition, methods of use thereof and articles protected from attachment of biofouling organisms
GB2159056A (en) Biocidal compositions comprising polyhydroxynaphthoquinones
CN110724149B (en) Indole alkaloid dimer compound derived from marine fungi, preparation method and application of indole alkaloid dimer compound in marine fouling organism resistant control agent
JPH03287507A (en) Fouling organism-controlling agent and anti-fouling paint composition
JPS6341495A (en) Polycyclic terpenoid glycoside and antifouling paint for repelling sticking of aquatic organism containing said glycoside
US20020022044A1 (en) Non-toxic coating composition, methods of use thereof and articles protected from attachment of biofouling organisms
JP2002241362A (en) 6-undecanesulfonic acid derivative and medicine and antibacterial agent containing the derivative as active component
JP2000119297A (en) New epidioxysterol
JPH10101502A (en) Antimicrobial agent
JPH09124586A (en) Antimicrobial and antifouling agent and beta-phenylethylamine derivative
JPH02247195A (en) Stilbene glycoside and antifouling coating composition containing the glycoside and effective in repelling adhesion of aquatic life
JPH1171212A (en) Industrial antibacterial/antifungal agent, algicide and anti-biofouling agent each containing thiadiazoleurea compound